Trial · NCT02524561
Participant flow36
How many started, completed or left each group, period by period.
1 to 20 of 36
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Baseline: Pre-randomization Mammogram | STARTED | CEE Pill, Active Progesterone | 168 | |
| Baseline: Pre-randomization Mammogram | STARTED | Estradiol Patch, Active Progesterone | 162 | |
| Baseline: Pre-randomization Mammogram | STARTED | Placebo | 187 | |
| Baseline: Pre-randomization Mammogram | Obtained Baseline Mammogram | CEE Pill, Active Progesterone | 137 | |
| Baseline: Pre-randomization Mammogram | Obtained Baseline Mammogram | Estradiol Patch, Active Progesterone | 133 | |
| Baseline: Pre-randomization Mammogram | Obtained Baseline Mammogram | Placebo | 151 | |
| Baseline: Pre-randomization Mammogram | COMPLETED | CEE Pill, Active Progesterone | 168 | |
| Baseline: Pre-randomization Mammogram | COMPLETED | Estradiol Patch, Active Progesterone | 162 | |
| Baseline: Pre-randomization Mammogram | COMPLETED | Placebo | 187 | |
| Baseline: Pre-randomization Mammogram | NOT COMPLETED | CEE Pill, Active Progesterone | 0 | |
| Baseline: Pre-randomization Mammogram | NOT COMPLETED | Estradiol Patch, Active Progesterone | 0 | |
| Baseline: Pre-randomization Mammogram | NOT COMPLETED | Placebo | 0 | |
| Year 1: Post Randomization Mammograms | STARTED | CEE Pill, Active Progesterone | 168 | |
| Year 1: Post Randomization Mammograms | STARTED | Estradiol Patch, Active Progesterone | 162 | |
| Year 1: Post Randomization Mammograms | STARTED | Placebo | 187 | |
| Year 1: Post Randomization Mammograms | Obtained Mammogam | CEE Pill, Active Progesterone | 136 | |
| Year 1: Post Randomization Mammograms | Obtained Mammogam | Estradiol Patch, Active Progesterone | 123 | |
| Year 1: Post Randomization Mammograms | Obtained Mammogam | Placebo | 148 | |
| Year 1: Post Randomization Mammograms | COMPLETED | CEE Pill, Active Progesterone | 168 | |
| Year 1: Post Randomization Mammograms | COMPLETED | Estradiol Patch, Active Progesterone | 162 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02524561/flow